Valesca Retel

Valesca Retel is an Endowed Professor at the Erasmus School of Health Policy & Management, specializing in Health Technology Assessment (HTA). Her work bridges health economics and oncology, focusing on the socioeconomic impacts of cancer care across Europe.

• Role: Endowed Professor in Health Technology Assessment
• Institution: Erasmus School of Health Policy & Management
• Department: Health Technology Assessment

Her research emphasizes cost-effectiveness analysis, pragmatic clinical trials, and genomic sequencing applications in oncology. Recent studies explore financial toxicity, biomarker testing frameworks, and support systems for adolescents with cancer.

Key article trends reveal a focus on economic evaluations (whole-genome sequencing in prostate cancer), European healthcare policy (socioeconomic support services), and pragmatic trial methodologies to enhance cancer treatment accessibility.